Status:
RECRUITING
A Survey of Midazolam in People With Status Epilepticus
Lead Sponsor:
Clinigen K.K.
Conditions:
Epilepsy
Eligibility:
All Genders
Brief Summary
This study is a survey in Japan of midazolam oromucosal solution used to treat people with status epilepticus. The study sponsor will not be involved in how the participants are treated but will provi...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Participants with non-convulsive status epilepticus
- Participants treated with study drug outside the medical institution
- Participants receiving an additional dose of study drug
- Exclusion Criteria Participants have any contraindication to midazolam.
Exclusion
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05313308
Start Date
June 1 2021
End Date
May 31 2027
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinigen selected site
Tokyo, Japan